Hubert Orfeuvre

1.9k total citations
37 papers, 1.1k citations indexed

About

Hubert Orfeuvre is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hubert Orfeuvre has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 11 papers in Reproductive Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hubert Orfeuvre's work include Cancer Treatment and Pharmacology (18 papers), Ovarian cancer diagnosis and treatment (11 papers) and HER2/EGFR in Cancer Research (8 papers). Hubert Orfeuvre is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), Ovarian cancer diagnosis and treatment (11 papers) and HER2/EGFR in Cancer Research (8 papers). Hubert Orfeuvre collaborates with scholars based in France, Belgium and United States. Hubert Orfeuvre's co-authors include Éric Pujade-Lauraine, B. Weber, Anne‐Claire Hardy‐Bessard, Hugues Bourgeois, D. Paraïso, Bernard Leduc, H. Curé, B. Audhuy, Véronique Dièras and R. Largillier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Hubert Orfeuvre

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hubert Orfeuvre

Since Specialization

Citations

This map shows the geographic impact of Hubert Orfeuvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Orfeuvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Orfeuvre more than expected).

Fields of papers citing papers by Hubert Orfeuvre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Orfeuvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Orfeuvre. The network helps show where Hubert Orfeuvre may publish in the future.

Co-authorship network of co-authors of Hubert Orfeuvre

This figure shows the co-authorship network connecting the top 25 collaborators of Hubert Orfeuvre. A scholar is included among the top collaborators of Hubert Orfeuvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubert Orfeuvre. Hubert Orfeuvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	167MO Association between ER, PR and HER2 levels and outcome under palbociclib (Pal) + aromatase inhibitors (AIs) as first-line therapy for ER+ HER2- metastatic breast cancer (MBC): An exploratory analysis of the PADA-1 trial 2022 ·Annals of Oncology ·Thibault De La Motte Rouge, Jean‐Sébastien Frenel, (unknown), (unknown), Barbara Pistilli, Suzette Delaloge, (unknown), (unknown), Dominique Genet, M. Gardner, Éric Legouffe, (unknown), Hubert Orfeuvre, (unknown), (unknown), Alain Zannetti, (unknown), Florence Dalenc, (unknown), (unknown)	3
2	GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer 2020 ·Anticancer Research ·Frédèric Selle, Pierre-Étienne Heudel, Anne‐Claire Hardy‐Bessard, Astrid Pozet, Jérôme Meunier, Laurence Gladieff, Jean‐Pierre Lotz, Magali Provansal, Paule Augereau, Dominique Berton, Nathalie Bonichon-Lamichhane, Hubert Orfeuvre, Patricia Pautier, Elsa Kalbacher, (unknown), Dominique Spaëth	7
3	Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study 2018 ·British Journal of Haematology ·Emmanuel Gyan, Anne Sonet, Pauline Brice, Bruno Anglaret, Kamel Laribi, Christophe Fruchart, Hervé Tilly, Carla Araujo, Pierre Soubeyran, (unknown), Nadine Morineau, Emmanuelle Nicolas‐Virelizier, Hervé Ghesquières, Bruno César Corrêa Salles, Réda Bouabdallah, Hubert Orfeuvre, (unknown), Olivier Couturier, Luc Xerri, Pierre Feugier	11
4	Outcomes of the combination trabectedin and pegylated liposomal doxorubicin (T-PLD) in recurrent platinum-sensitive ovarian cancer (OC): a GINECO cohort study 2017 ·Annals of Oncology ·Frédèric Selle, Pierre-Étienne Heudel, Youssef Tazi, Astrid Pozet, (unknown), Jérôme Meunier, Laurence Gladieff, (unknown), Magali Provansal, Paule Augereau, Jean‐Sébastien Frenel, Nathalie Bonichon-Lamichhane, Hubert Orfeuvre, Fanny Pommeret, (unknown), Elsa Kalbacher, C. Roemer-Bécuwe	1
5	A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study 2016 ·Annals of Oncology ·Olivier Trédan, Philippe Follana, Isabelle Moullet, Claire Cropet, (unknown), Jérôme Dauba, Sandrine Lavau‐Denès, Véronique Dièras, (unknown), (unknown), Hubert Orfeuvre, Laëtitia Stefani, Christelle Jouannaud, F Bürki, Thierry Petit, Emmanuel Guardiola, (unknown), Emmanuel Blot, Éric Pujade-Lauraine, Thomas Bachelot	19
6	Description des modalités pratiques de prescription d’un facteur de croissance de la lignée granulocytaire (G-CSF) chez les patientes recevant une chimiothérapie pour un cancer du sein : étude Opaline 2015 ·Bulletin du Cancer ·William Jacot, Éric-Charles Antoine, Maya Hacini, (unknown), Alain Rivière, Laurence Moureau-Zabotto, (unknown), (unknown), Hubert Orfeuvre, (unknown), (unknown), Laurent Bastit, (unknown), D. Azria	2
7	Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma 2012 ·Journal of Hematology & Oncology ·Adrien Chauchet, Anne‐Sophie Michallet, Françoise Berger, (unknown), Éric Deconinck, Catherine Sebban, Daciana Antal, Hubert Orfeuvre, Bernadette Corront, Tony Petrella, Maya Hacini, Marie Bouteloup, Gilles Salles, Bertrand Coiffier	29
8	Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients 2011 ·American Journal of Clinical Oncology ·Jean-Philippe Jacquin, Cyrus Chargari, (unknown), (unknown), (unknown), Hubert Orfeuvre, (unknown), L. Chaigneau, Alice Nourissat, (unknown), J. Savary, Yacine Merrouche, Nicolas Magné	11
9	Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE 2009 ·Annals of Oncology ·Christelle de la Fouchardière, R. Largillier, (unknown), Anne‐Claire Hardy‐Bessard, Borhane Slama, J Crétin, Hubert Orfeuvre, D. Paraïso, Thomas Bachelot, Éric Pujade-Lauraine	10
10	Un déficit sévère en G6PD découvert au décours d'une chimiothérapie avec utilisation de rasburicase 2009 ·Annales de biologie clinique ·(unknown), (unknown), Alain Francina, (unknown), (unknown), Hubert Orfeuvre	2
11	Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group 2009 ·British Journal of Cancer ·(unknown), Isabelle Ray‐Coquard, B. Weber, J Crétin, (unknown), E. Lévy, Anne‐Claire Hardy‐Bessard, M.C. Gouttebel, (unknown), (unknown), Hubert Orfeuvre, (unknown), J. Provençal, Jean-Marc Ferrero, (unknown), Nadine Dohollou, D. Paraïso, J Salvat, Éric Pujade-Lauraine	20
12	Use of the Monoclonal Antibody Anti-HER2 Trastuzumab in the Treatment of Metastatic Breast Cancer 2008 ·American Journal of Clinical Oncology ·Bénédicte Poncet, Thomas Bachelot, Cyrille Colin, (unknown), (unknown), Hubert Orfeuvre, (unknown), Jean-Philippe Jacquin, Bruno César Corrêa Salles, J Tigaud, (unknown), (unknown), (unknown), (unknown)	21
13	A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study 2007 ·Breast Cancer Research and Treatment ·Philippe A. Cassier, Sylvie Chabaud, V. Trillet-Lenoir, (unknown), J Tigaud, Hervé Curé, Hubert Orfeuvre, Bruno César Corrêa Salles, C. Martin, Jean-Philippe Jacquin, (unknown), Jean‐Paul Guastalla, David Pérol, Thomas Bachelot	32
14	Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial 2006 ·Annals of Oncology ·Jean-Marc Ferrero, B. Weber, J.-F. Geay, D. Lepillé, Hubert Orfeuvre, M. Combe, F. Mayer, Bernard Leduc, Hugues Bourgeois, D. Paraïso, Éric Pujade-Lauraine	86
15	Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer 2003 ·European Journal of Cancer ·P. Fumoleau, R. Largillier, (unknown), Véronique Dièras, Hubert Orfeuvre, Thierry Lesimple, Stéphane Culine, B. Audhuy, D. Serin, H. Curé, E. Vuillemin, Jean‐François Morère, François Montestruc, (unknown), M. Namer	247
16	HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group 2003 ·Annals of Oncology ·Sophie Camilleri‐Broët, Anne‐Claire Hardy‐Bessard, A. Le Tourneau, D. Paraïso, Olivier Levrel, Bernard Leduc, Stacey Bain, Hubert Orfeuvre, Josée Audouin, Éric Pujade-Lauraine	80
17	Oral vinorelbine: Feasibility and safety profile 2001 ·Annals of Oncology ·A Depierre, Gilles Freyer, Jacek Jassem, Hubert Orfeuvre, Rodryg Ramlau, É. Lemarié, P. Koralewski, L. Mauriac, Jean-Luc Breton, T. Delozier, V. Trillet-Lenoir	42
18	Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma 1998 ·Annals of Oncology ·Jean‐Paul Guastalla, Éric Pujade-Lauraine, B. Weber, H. Curé, Hubert Orfeuvre, M Mousseau, (unknown), V. Diéras, N. Tubiana-Mathieu, J.P. Jacquin, L. Mignot, Bernard Leduc, Patrice Viens, (unknown)	35
19	A recent increase in the incidence of prostatic carcinoma in a French population: Role of ultrasonography and prostatic specific antigen 1995 ·European Journal of Cancer ·F Ménégoz, Marc Colonna, C. Exbrayat, M Mousseau, Hubert Orfeuvre, R Schaerer	24
20	Role of autologous lymph node T cells in membrane expression of Mu‐ or Gamma‐ heavy chain isotype by malignant B NHL cells 1989 ·European Journal Of Haematology ·Thierry Bonnefoix, Hubert Orfeuvre, Marie‐Christine Jacob, Marie‐Pierre Piccinni, Jean‐Jacques Sotto	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact